Published in Medical Letter on the CDC and FDA, April 5th, 2009
Called the COMPARE Trial, the National Institutes of Health-funded study conducted at the University of Florida evaluated 45 patients for mood and cognitive changes related to DBS.
UF investigators found that DBS in either brain target effectively treated motor symptoms such as tremors, stiffness and slowness.
However, DBS also produced unique effects depending on the target...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA